Prepare for your Anatomy and Physiology II Exam with our comprehensive exam resources. Utilize flashcards, multiple choice questions with hints, and detailed explanations. Boost your readiness for success!

Multiple Choice

Why are the pancreas’ inactive proenzymes not released in their active form?

Pancreatic digestive enzymes are made as inactive proenzymes to prevent them from digesting the pancreas itself. If these proteases were released in their active form, they could start breaking down pancreatic tissue and ducts, leading to damage such as pancreatitis. To avoid this, the enzymes are stored and secreted as inactive zymogens and only activated later in the digestive tract. Activation occurs in the small intestine. An intestinal enzyme called enteropeptidase converts trypsinogen into trypsin, and then trypsin activates the other zymogens like chymotrypsinogen and the procarboxypeptidases. This setup confines proteolytic activity to the intestinal lumen, away from pancreatic tissue. The pancreas also uses protease inhibitors to catch any proteases that might become active inside the gland. Thus, the main reason the pancreas keeps its enzymes inactive until they reach the intestine is to protect its own secretory cells from their destructive products. The other options don’t fit because they describe roles unrelated to protecting pancreatic tissue: enzyme activity is not aimed at the stomach environment, bile production, or insulin secretion.

Pancreatic digestive enzymes are made as inactive proenzymes to prevent them from digesting the pancreas itself. If these proteases were released in their active form, they could start breaking down pancreatic tissue and ducts, leading to damage such as pancreatitis. To avoid this, the enzymes are stored and secreted as inactive zymogens and only activated later in the digestive tract.

Activation occurs in the small intestine. An intestinal enzyme called enteropeptidase converts trypsinogen into trypsin, and then trypsin activates the other zymogens like chymotrypsinogen and the procarboxypeptidases. This setup confines proteolytic activity to the intestinal lumen, away from pancreatic tissue. The pancreas also uses protease inhibitors to catch any proteases that might become active inside the gland.

Thus, the main reason the pancreas keeps its enzymes inactive until they reach the intestine is to protect its own secretory cells from their destructive products. The other options don’t fit because they describe roles unrelated to protecting pancreatic tissue: enzyme activity is not aimed at the stomach environment, bile production, or insulin secretion.